Molecular Diagnostics World Summit 2016
Advancement of Next Generation Diagnostics for efficient diagnosis
Conference Focus
The global molecular diagnostics market is predicted to reach $8 billion by 2018. This market is highly influenced by the raise of infectious diseases such as TB, HIV etc, antimicrobial resistance and other factors. 80% of the market are shared between Europe and America and remaining 20% between Rest of the World. To provide efficient treatment and disease management there is an urgent need for rapid and more efficient diagnostics. In terms of technology PCR based diagnostics are rapidly growing and possess the major market shares. NGS, POC, Microarrays and others form the rest of the market. Molecular Diagnostics market comprises of instruments, reagents, software and end user services which has a great future and growth by 2018.
Thus, Molecular Diagnostics World Summit 2016, conference offers a rare opportunity to its participants to understand and learn from top experts in the Molecular Microbiology and Diagnostics field and to share ideas and develop new business collaborations. The conference will also provide a platform to discuss the current vital issues, market assessment, commercialization and globalization.
The conference will bring together industry experts to explore and gain insight into new molecular diagnostics development strategies, development from research to the Market and successful case studies.
It gives us a great pleasure in welcoming you to the Molecular Diagnostics World Summit 2016.
Key themes to be discussed
ï‚· Point of Care Testing
ï‚· PCR
ï‚· NGS
ï‚· Antimicrobial Resistance
ï‚· Infectious Diseases / Cancer
ï‚· Future of Molecular Diagnostics
ï‚· Funding Opportunities / Collaborations
Why should you attend the conference?
With better communication, socializing and networking, new strategies and improvisations we can stay ahead with the rapidly growing Diagnostics Market and develop new technologies from pipeline to commercialisation through networking and partnerships.
Who should attend the conference?
VPs, Directors, Heads, Managers, Scientific Advisors, Consultants, Senior scientists, Project Leaders, Research Scholars, Academicians, and all professionals with intermediate to advance knowledge and experience in the following
Expression Systems Immunogenicity Testing
Intellectual Property Molecular Testing
Market Entry Molecular Biology
Product Development Molecular Diagnostics
Bioanalytics Next Generation Sequencing
Bioinformatics Partnering and Licensing
Biomanufacturing Patient Safety
Biotechnology Protein Characterization
Clinical Diagnostics Small and Medium-sized
Clinical Immunology Venture Capitalist
Clinical Microbiology
Commercial Biologics
Development
Note: Please email your abstracts for Poster Presentation by 31st January 2016 to
sharon@gravitonevents.org
Advancement of Next Generation Diagnostics for efficient diagnosis
Conference Focus
The global molecular diagnostics market is predicted to reach $8 billion by 2018. This market is highly influenced by the raise of infectious diseases such as TB, HIV etc, antimicrobial resistance and other factors. 80% of the market are shared between Europe and America and remaining 20% between Rest of the World. To provide efficient treatment and disease management there is an urgent need for rapid and more efficient diagnostics. In terms of technology PCR based diagnostics are rapidly growing and possess the major market shares. NGS, POC, Microarrays and others form the rest of the market. Molecular Diagnostics market comprises of instruments, reagents, software and end user services which has a great future and growth by 2018.
Thus, Molecular Diagnostics World Summit 2016, conference offers a rare opportunity to its participants to understand and learn from top experts in the Molecular Microbiology and Diagnostics field and to share ideas and develop new business collaborations. The conference will also provide a platform to discuss the current vital issues, market assessment, commercialization and globalization.
The conference will bring together industry experts to explore and gain insight into new molecular diagnostics development strategies, development from research to the Market and successful case studies.
It gives us a great pleasure in welcoming you to the Molecular Diagnostics World Summit 2016.
Key themes to be discussed
ï‚· Point of Care Testing
ï‚· PCR
ï‚· NGS
ï‚· Antimicrobial Resistance
ï‚· Infectious Diseases / Cancer
ï‚· Future of Molecular Diagnostics
ï‚· Funding Opportunities / Collaborations
Why should you attend the conference?
With better communication, socializing and networking, new strategies and improvisations we can stay ahead with the rapidly growing Diagnostics Market and develop new technologies from pipeline to commercialisation through networking and partnerships.
Who should attend the conference?
VPs, Directors, Heads, Managers, Scientific Advisors, Consultants, Senior scientists, Project Leaders, Research Scholars, Academicians, and all professionals with intermediate to advance knowledge and experience in the following
Expression Systems Immunogenicity Testing
Intellectual Property Molecular Testing
Market Entry Molecular Biology
Product Development Molecular Diagnostics
Bioanalytics Next Generation Sequencing
Bioinformatics Partnering and Licensing
Biomanufacturing Patient Safety
Biotechnology Protein Characterization
Clinical Diagnostics Small and Medium-sized
Clinical Immunology Venture Capitalist
Clinical Microbiology
Commercial Biologics
Development
Note: Please email your abstracts for Poster Presentation by 31st January 2016 to
sharon@gravitonevents.org
